acquired methemoglobinemia

ac·quired met·he·mo·glo·bi·ne·mi·a

methemoglobinemia caused by various chemical agents, such as nitrites or topical anesthetics.

ac·quired me·the·mo·glo·bi·ne·mi·a

(ă-kwīrd met-hēmō-glōbi-nēmē-ă)
Form caused by various chemical agents.
References in periodicals archive ?
Dapsone is a common cause of acquired methemoglobinemia.
I would like to add to this well written article that we have also reported acquired methemoglobinemia cases with administration of cytanest in puerperal women with G6PD deficiency and infants in whom erythrocyte cytochrome 65 reductase was assoyed (1-4), which is the main enzyme for methemoglobin reductase in erythrocytes as mentioned by the authors.
Drugs that cause acquired methemoglobinemia are prevalent in both the hospital and the outpatient setting.
6 /PRNewswire-FirstCall/ -- Masimo , the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that a new study presented at the Society for Critical Care Medicine 38th Critical Care Congress suggests providers should consider routine screening with Masimo Rainbow SET Pulse CO-Oximetry for the immediate and noninvasive detection of potentially life-threatening acquired methemoglobinemia in patients receiving Dapsone therapy.
Acquired methemoglobinemia and hemolytic anemia following excessive pyridium (phenazopyridine hydrochloride) ingestion.
3) reviewed 138 acquired methemoglobinemia cases, of which 42% were caused by dapsone, followed by benzocaine (4%) and primaquine (4%).
Objective: This study aimed to determine the etiologic factors of acquired methemoglobinemia in infants younger than three months in our region.
The Institute for Safe Medical Practice (ISMP) states that "methemoglobinemia is unlikely to be a rare occurrence", while authors from the 2004 Johns Hopkins University School of Medicine study(i) entitled "Acquired Methemoglobinemia", concluded "drugs that cause acquired methemoglobinemia are ubiquitous in both the hospital and the outpatient setting.
Treatment of high-risk, refractory acquired methemoglobinemia with automated red cell blood cell exchange.
The Institute for Safe Medical Practice (ISMP) states that "methemoglobinemia is unlikely to be a rare occurrence" while authors from The 2004 Johns Hopkins University School of Medicine study(I) entitled "Acquired Methemoglobinemia," concluded "drugs that cause acquired methemoglobinemia are ubiquitous in both the hospital and the outpatient setting.
Ascorbic acid is not indicated in the treatment of acquired methemoglobinemia because the rate at which it reduces methemoglobin is lower than that of the intrinsic enzymatic pathways (24, 35).

Full browser ?